Shuyan Han

1.9k total citations
57 papers, 1.5k citations indexed

About

Shuyan Han is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shuyan Han has authored 57 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 20 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shuyan Han's work include Lung Cancer Treatments and Mutations (7 papers), Phytochemistry and Bioactive Compounds (6 papers) and Ginseng Biological Effects and Applications (4 papers). Shuyan Han is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Phytochemistry and Bioactive Compounds (6 papers) and Ginseng Biological Effects and Applications (4 papers). Shuyan Han collaborates with scholars based in China, Ethiopia and United States. Shuyan Han's co-authors include Pingping Li, Haixia Li, Xu Ma, Zhizhong Ma, Yanna Jiao, Shantong Jiang, Xiran He, Pengfei Tu, Peng‐Fei Tu and Huifeng Hao and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Shuyan Han

56 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuyan Han China 23 651 267 235 226 211 57 1.5k
Ali Alhoshani Saudi Arabia 25 497 0.8× 347 1.3× 177 0.8× 83 0.4× 64 0.3× 73 1.6k
Yanhua Fan China 22 467 0.7× 142 0.5× 252 1.1× 41 0.2× 93 0.4× 95 1.4k
Yubo Zhou China 28 1.7k 2.6× 469 1.8× 121 0.5× 65 0.3× 65 0.3× 171 2.8k
Congcong Chen China 25 917 1.4× 103 0.4× 452 1.9× 41 0.2× 124 0.6× 80 1.9k
Yoon‐Jin Lee South Korea 22 819 1.3× 303 1.1× 233 1.0× 26 0.1× 108 0.5× 77 1.6k
Zhonghong Gao China 19 533 0.8× 102 0.4× 164 0.7× 104 0.5× 37 0.2× 52 1.6k
Chenglong Sun China 21 939 1.4× 72 0.3× 137 0.6× 83 0.4× 105 0.5× 60 1.5k
Wenyu Xin China 21 590 0.9× 88 0.3× 62 0.3× 141 0.6× 25 0.1× 47 1.2k
Qiang Ren China 19 457 0.7× 59 0.2× 143 0.6× 73 0.3× 78 0.4× 73 1.2k
Arghya Adhikary India 32 1.2k 1.8× 477 1.8× 351 1.5× 204 0.9× 14 0.1× 82 2.6k

Countries citing papers authored by Shuyan Han

Since Specialization
Citations

This map shows the geographic impact of Shuyan Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuyan Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuyan Han more than expected).

Fields of papers citing papers by Shuyan Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuyan Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuyan Han. The network helps show where Shuyan Han may publish in the future.

Co-authorship network of co-authors of Shuyan Han

This figure shows the co-authorship network connecting the top 25 collaborators of Shuyan Han. A scholar is included among the top collaborators of Shuyan Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuyan Han. Shuyan Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Lan, Chengyuan Yang, Shuyan Han, et al.. (2025). Generating research hypotheses to overcome key challenges in the early diagnosis of colorectal cancer - Future application of AI. Cancer Letters. 620. 217632–217632. 1 indexed citations
2.
Wang, Xin, et al.. (2025). Characterization, in vitro release, and pharmacokinetics of rupestonic acid derivative nanostructured lipid carriers optimized by Box-Behnken design. Journal of Pharmaceutical Sciences. 115(2). 104070–104070. 1 indexed citations
3.
Zhang, Zhenguo, Peng Chen, Shuyan Han, et al.. (2024). Triaryl Carbenium Ion Pair Mediated Electrocatalytic Benzylic C−H Oxygenation in Air. Angewandte Chemie International Edition. 63(28). e202406588–e202406588. 11 indexed citations
4.
5.
Yuan, Yuan, Xinxin Deng, Shan Wang, & Shuyan Han. (2023). Comprehensive pan-cancer analysis identifies centromere-associated protein E as a novel prognostic and immunological biomarker in human tumors. Biochimica et Biophysica Acta (BBA) - General Subjects. 1867(6). 130346–130346. 3 indexed citations
6.
Li, Chenggang, et al.. (2023). A review on the mechanisms underlying the antitumor effects of natural products by targeting the endoplasmic reticulum stress apoptosis pathway. Frontiers in Pharmacology. 14. 1293130–1293130. 8 indexed citations
7.
Hao, Huifeng, et al.. (2022). Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF. Journal of Ethnopharmacology. 298. 115607–115607. 20 indexed citations
8.
Ma, Zhihui, Shuyan Han, & Shenghua Li. (2021). A stochastic eco-epidemiological system with patchy structure and transport-related infection. Journal of Mathematical Biology. 83(6-7). 62–62. 2 indexed citations
9.
Hao, Huifeng, Haiyu Zhao, Wei Ren, et al.. (2020). Marsdenia tenacissima extract promotes gefitinib accumulation in tumor tissues of lung cancer xenograft mice via inhibiting ABCG2 activity. Journal of Ethnopharmacology. 255. 112770–112770. 10 indexed citations
10.
Han, Shuyan, Akitoshi Ogawa, Takahiro Osada, et al.. (2019). More subjects are required for ventrolateral than dorsolateral prefrontal TMS because of intolerability and potential drop-out. PLoS ONE. 14(6). e0217826–e0217826. 7 indexed citations
11.
Li, Zhandong, Huifeng Hao, Yanna Jiao, et al.. (2019). Nitric oxide, a communicator between tumor cells and endothelial cells, mediates the anti-tumor effects of Marsdenia Tenacissima Extract (MTE). Journal of Ethnopharmacology. 250. 112524–112524. 9 indexed citations
12.
Jiao, Yanna, Lina Wu, Dong Xue, et al.. (2018). Marsdenia tenacissima extract induces apoptosis and suppresses autophagy through ERK activation in lung cancer cells. Cancer Cell International. 18(1). 149–149. 52 indexed citations
14.
Han, Shuyan, et al.. (2016). Xiaoaiping injection combined with gefitinib inhibits resistant non-small cell lung cancer xenografts H460 and H1975. 30(1). 52. 1 indexed citations
15.
Zheng, Nan, Xiran He, Shantong Jiang, et al.. (2016). Simultaneous determination of gefitinib and its major metabolites in mouse plasma by HPLC–MS/MS and its application to a pharmacokinetics study. Journal of Chromatography B. 1011. 215–222. 34 indexed citations
16.
Ma, Xu, et al.. (2013). Extracts from Astragalus membranaceus limit myocardial cell death and improve cardiac function in a rat model of myocardial ischemia. Journal of Ethnopharmacology. 149(3). 720–728. 61 indexed citations
17.
Han, Shuyan, Haixia Li, Xu Ma, et al.. (2012). Evaluation of the anti-myocardial ischemia effect of individual and combined extracts of Panax notoginseng and Carthamus tinctorius in rats. Journal of Ethnopharmacology. 145(3). 722–727. 65 indexed citations
18.
Han, Shuyan, et al.. (2011). Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells. Lung Cancer. 75(1). 30–37. 64 indexed citations
19.
Han, Shuyan, et al.. (2009). Protective effects of purified safflower extract on myocardial ischemia in vivo and in vitro. Phytomedicine. 16(8). 694–702. 64 indexed citations
20.
Han, Shuyan & Pingping Li. (2009). Progress of research in antitumor mechanisms with Chinese medicine. Chinese Journal of Integrative Medicine. 15(4). 316–320. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026